Oxaliplatin-induced Sudden Hearing Loss in a Patient with Pancreatic Cancer
Oxaliplatin is a new generation of platinum derivatives used frequently to treat solid organ malignancies, including colorectal and ovarian cancer. Recently, an oxaliplatin-based chemotherapeutic regimen was adopted for advanced pancreatic cancer. Although oxaliplatin has extensive therapeutic poten...
Main Authors: | Sung Bum Kim, So Yeong Kim, Kook Hyun Kim, Tae Nyeun Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Jin Publishing & Printing Co.
2020-11-01
|
Series: | The Korean Journal of Gastroenterology |
Subjects: | |
Online Access: | http://www.kjg.or.kr/journal/view.html?uid=5644&vmd=Full |
Similar Items
-
Oxaliplatin-Induced Thrombotic Microangiopathy in a Patient with Stage IV Gallbladder Carcinoma: Primary Association or Multiple Hits?
by: María Cynthia Fuentes-Lacouture, et al.
Published: (2020-09-01) -
A phase II trial of S-1 and oxaliplatin in patients with advanced hepatocellular carcinoma
by: Dae-Won Lee, et al.
Published: (2018-03-01) -
Identification of New Regulators of Pancreatic Cancer Cell Sensitivity to Oxaliplatin and Cisplatin
by: Vera Skripova, et al.
Published: (2022-02-01) -
Variant Hypersensitivity Reaction (HSR) Presented with Persistent Dry Cough after Receiving Oxaliplatin in a Pancreatic Cancer Patient
by: Jia Li, et al.
Published: (2009-09-01) -
Efficacy of Capecitabine Plus Oxaliplatin Combination Chemotherapy for Advanced Pancreatic Cancer after Failure of First-Line Gemcitabine-Based Therapy
by: Kwang Hyun Chung, et al.
Published: (2017-03-01)